Burning Rock Biotech annual capital expenditures (capex)
2020
2021
2022
2023
2024
2025
Burning Rock Biotech Capital Expenditures (CapEx) Growth & History (BNR)
Burning Rock Biotech's capital expenditures (capex) was $751,000 for fiscal 2025.
View full Burning Rock Biotech company overviewBurning Rock Biotech annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $751,000 | $9,000 | +1.21% |
| 2024 | 2024-12-31 | $742,000 | −$399,000 | −34.97% |
| 2023 | 2023-12-31 | $1.1M | −$7.9M | −87.31% |
| 2022 | 2022-12-31 | $9.0M | −$23.1M | −71.95% |
| 2021 | 2021-12-31 | $32.1M | $22.8M | +247.06% |
| 2020 | 2020-12-31 | $9.2M | — | — |
Burning Rock Biotech capital expenditures (capex) trends
Over the last five fiscal years, Burning Rock Biotech's capital expenditures (capex) decreased from $9.2M to $751,000, a change of −$8.5M.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Burning Rock Biotech source filings ↗